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Structure of Aspergillus niger epoxide hydrolase at 1.8 Å
resolution: implications for the structure and function of the
mammalian microsomal class of epoxide hydrolases
Jinyu Zou1, B Martin Hallberg1, Terese Bergfors1, Franz Oesch2,
Michael Arand2, Sherry L Mowbray3 and T Alwyn Jones1*
Background: Epoxide hydrolases have important roles in the defense of cells
against potentially harmful epoxides. Conversion of epoxides into less toxic and
more easily excreted diols is a universally successful strategy. A number of
microorganisms employ the same chemistry to process epoxides for use as
carbon sources.
Results: The X-ray structure of the epoxide hydrolase from Aspergillus niger
was determined at 3.5 Å resolution using the multiwavelength anomalous
dispersion (MAD) method, and then refined at 1.8 Å resolution. There is a dimer
consisting of two 44 kDa subunits in the asymmetric unit. Each subunit consists
of an α/β hydrolase fold, and a primarily helical lid over the active site. The
dimer interface includes lid–lid interactions as well as contributions from an
N-terminal meander. The active site contains a classical catalytic triad, and two
tyrosines and a glutamic acid residue that are likely to assist in catalysis.
Conclusions: The Aspergillus enzyme provides the first structure of an epoxide
hydrolase with strong relationships to the most important enzyme of human
epoxide metabolism, the microsomal epoxide hydrolase. Differences in 
active-site residues, especially in components that assist in epoxide ring
opening and hydrolysis of the enzyme–substrate intermediate, might explain
why the fungal enzyme attains the greater speeds necessary for an effective
metabolic enzyme. The N-terminal domain that is characteristic of microsomal
epoxide hydrolases corresponds to a meander that is critical for dimer
formation in the Aspergillus enzyme.
Introduction
Epoxides are frequent intermediates in the metabolism of
lipophilic xenobiotics. Because of their high ring tension
and polarized C–O bonds, they are often electrophilically
reactive, forming adducts with cellular DNA and so pro-
ducing mutations that can cause cancer. Epoxide hydro-
lases (EH; EC 3.3.2.3) convert epoxides to the more
water-soluble and usually less toxic diols, and are therefore
key enzymes in the defense of the human organism against
the hazardous properties of xenobiotic compounds [1]. 
The epoxide hydrolase implicated in most metabolism
of xenobiotics in mammals is the membrane-bound
microsomal epoxide hydrolase (mEH; [2]). It is particu-
larly abundant in human liver, the major site of foreign-
compound metabolism. A second EH that is also capable
of hydrolyzing xenobiotic epoxides is the soluble
epoxide hydrolase (sEH; [3]). Although direct sequence
comparison of the two mammalian EHs did not at 
first suggest a structural relationship [4], the low yet
significant sequence similarity of each enzyme to the
bacterial haloalkane dehalogenase (HAD; [5]) indicated
a common origin [6].
This relationship gave many clues about the chemistry to
be expected for the EH reaction. HAD belongs to the class
of α/β hydrolase fold enzymes [7,8] that, despite a gener-
ally low sequence similarity, are thought to be of common
phylogenetic origin. The catalytic triad of HAD is com-
posed of Asp124–Asp260–His289, with Asp124 being the
catalytic nucleophile needed to form an ester intermediate
with the substrate dichloroethane [9,10]. This ester inter-
mediate differs from that of the classical serine hydrolases,
such as acetylcholine esterase, in that the acid component
is derived from the enzyme rather than from the substrate.
The product release is afforded by hydrolytic cleavage of
the covalent intermediate through attack of a water mol-
ecule activated by the His289–Asp260 charge-relay system
[11]. Sequence comparisons suggest a conservation of this
catalytic triad in both mammalian EHs [6,12,13], which
has more recently been substantiated using biochemical
characterization of the proteins [14–18].
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Over the past several years, a growing number of EHs
have been identified in microorganisms, largely motivated
by their potential as enantioselective biocatalysts for the
chiral synthesis of fine chemicals, for example drug pre-
cursors. At present, all of these can be classified as α/β
hydrolase fold enzymes, with only a single exception [19].
The solution of the structure of the EH from Agrobac-
terium radiobacter [20] gave the first picture of an EH
structure, and many insights into the sEH family. We
have recently reported the cloning and molecular analysis
of an epoxide hydrolase from the fungus Aspergillus niger
(AnEH; [21]). This enzyme is especially interesting for
two reasons. First, it is a particularly useful biocatalyst
because it shows exceptionally fast substrate turnover as
compared with other EHs, while at the same time being
highly enantioselective towards industrially important
epoxides [22]. Second, and of broader interest, it is the
first known soluble member of the family of mEHs.
Structural information about this branch of the EH
enzymes has previously been unobtainable, largely
because of the difficulties in crystallizing membrane pro-
teins. AnEH thus offers an excellent opportunity to study
some basic features of the enzymatic reaction of mEHs
that have previously been hard to address. One important
question is the nature of the proton donor that, through
interactions with the epoxide ring oxygen atom, is
expected to assist in enzymatic attack. A second puzzle
centers on the reasons why trans-substituted epoxides are
generally not hydrolyzed by the mEHs, despite the other-
wise promiscuous substrate selectivity of these enzymes.
Third, the function of the long N-terminal extension
(~90 residues) preceding the α/β hydrolase fold in the
mEH family has remained obscure. A possible role in
molecular interactions with other drug-metabolizing
enzymes (for example cytochromes P450, UDP-glu-
curonosyl transferases) for efficient substrate channeling
is conceivable but has not, as yet, been tested.
In the present paper, we describe the three-dimensional
structure of AnEH determined at a resolution of 1.8 Å, the
first structure of the mEH family to be solved.
Results and discussion
The three-dimensional crystal structure was determined
at 3.5 Å resolution by the multiwavelength anomalous dif-
fraction (MAD) method using crystals of a seleno-methio-
nine (SeMet) substituted form of the enzyme. The model
was then refined at 1.8 Å resolution to a crystallographic R
factor of 22.5% and an Rfree [23] of 23.3%. There are two
subunits of epoxide hydrolase in the asymmetric unit,
with a dimer formed around a nearly perfect (179.2°) non-
crystallographic twofold axis. The current model includes
residues 3–396 (out of 398), except for the partially disor-
dered residues from 320–328. Because of the expression
construct used, the sequence KA (in single-letter amino
acid code) is present at residues 3–4 instead of the AP of
the wild-type protein (see the Materials and methods
section). A total of 374 water molecules are included.
Some statistics for the X-ray data collection and refine-
ment are shown in Tables 1 and 2.
Overall structure and fold of the subunit
The epoxide hydrolase subunit can be divided into three
parts: a core α/β domain that contains the active-site
residues, a lid protruding from this domain (that caps the
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Table 1
Data collection statistics.
Native Se-AnEH Se-AnEH Se-AnEH
Peak Inflection Remote
Wavelength (Å) 0.937 0.9794 0.9796 0.9312
Resolution (Å) 1.8–50 2.7–30 2.7–30 2.7–30
No. observations 263,931 161,798 163,833 163,296
No. unique reflections 74,416 22,522 22,587 22,546
Completeness (%) 99.8 (99.9) 99.5 (98.5) 99.5 (98.4) 99.6 (99.6)
Rmerge* (%) 7.3 (32.1) 5.1 (12) 5.8 (17) 6.1 (10.4)
Average I/σ(I)† 15 (5) 11 (5) 10 (4) 13 (6)
Anomalous – 5.6 4.1 4.8
differences (%)†‡
Dispersive differences to – 4.8 4.9 –
remote wavelength (%)†‡
Refined scattering – –8.1/7.3 –8.5/3.5 –1.7/3.3
factors f′/f′′ (e–)†‡
FOM‡ – – – 0.81
FOM after DM‡ – – – 0.84
FOM after twofold – – – 0.88
averaging in DM‡
Both the native and Se-AnEH crystallized in space group P21. The
unit-cell dimensions were a = 62.7 Å, b = 89.3 Å, c = 75.8 Å and
β = 105° for the native protein, and a = 62.8 Å, b = 89.8 Å, c = 75.7 Å
and β = 105.4° for the Se-AnEH protein. Statistics for the highest
resolution shells, 1.86–1.80 Å for the native protein and 2.8–2.7 Å for
Se-AnEH, are given in parentheses. *As taken from SCALEPACK [49].
†As taken from SOLVE [47]. ‡Valid for data truncated to 3.5 Å
resolution. FOM, figure of merit.
Table 2
Refinement statistics.
Resolution range (Å) 20.0–1.8
No. of reflections 74,309
No. of reflections used for Rfree calculation 1524
R value, Rfree value (%) 22.5, 23.3
No. of non-hydrogen protein atoms 6128
No. of solvent waters 374
Mean B factor, protein mainchain atoms (Å2) 22.3
Mean B factor, protein sidechain atoms (Å2) 23.2
Average B factor, solvent atoms (Å2) 30.4
Ramachandran plot outliers (%)* 2.5
Rms deviation bond length (Å) 0.006
Rms deviation bond angle (°) 1.3
Rms difference NCS, on Cα atoms (Å) 0.020
Rms difference NCS, on all atoms (Å) 0.023
Rms difference NCS ∆B, on Cα atoms (Å2) 0.35
Rms difference NCS ∆B, on all atoms (Å2) 0.38
*A stringent-boundary Ramachandran plot was used [60].
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active site), and a long N-terminal meander that in turn
caps the lid (Figures 1a,b).
The α/β fold follows the classic design of an α/β hydrolase
[8], consisting of a twisted eight-stranded β sheet flanked
on both faces by α helices. As in the canonical fold, all
strands are parallel, except the second, which is antiparal-
lel (Figure 1b). The two Ramachandran outliers are
common features of the α/β hydrolase family. The first
involves the mainchain conformation of the active-site
nucleophile (in this case Asp192). The second lies in the
insert at the C-terminal end of β4 (normally a glycine
residue in the closest family members, but in this case
Thr153). This insert has a highly conserved sequence and
has been used as one of the key motifs for epoxide
hydrolase identification in genomic sequence searches
(M Arand, unpublished observations). Its function appears
to be to create a niche to support one of the helices
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Figure 1
Structure of AnEH. (a) Cα trace, with colors
going through the rainbow from red at the
N terminus to blue at the C terminus. The
sidechains of the catalytic triad (Asp192,
His374 and Asp348), Tyr251, Tyr314, and
Glu123 are shown in red. The approximate
placement of residues 320–328 (omitted from
the final model) is indicated by dotted lines.
(b) Topology diagram colored using the same
rainbow scheme. Secondary-structure
descriptors for the α/β domain follow earlier
nomenclature [7], whereas the N-terminal
meander and lid domains use separate
systems, prefixed with N and L, respectively.
Residues of the catalytic triad are indicated by
red stars, and the two active-site tyrosine
residues of the lid by magenta stars.
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making up the active-site lid. Strand β6 ends at residue
214 and the chain then makes a sharp change in direction.
The space next to the abutting helix αC is poorly packed
with sidechains, creating a solvent-accessible tunnel that
reaches to the catalytic nucleophile at residue 192. The
α/β hydrolase domain continues from residue 329. Most of
the intervening region is made up by the lid.
In AnEH, the lid is composed of six α helices correspond-
ing to residues 231–319. The first helix leads up to the
active site, then αLB (where the prefix L denotes the lid
domain) bridges it. Helices αLB, αLC and αLD together
form a nearly triangular arrangement; αLD is somewhat
curved, with a bend near Trp276. Another change in
direction brings αLE and αLF back, such that these two
helices are wedged between the triangle and the α/β
hydrolase domain. Helix αLF is distorted near Tyr314,
whose sidechain points into the active site. The residues
(320–328) that link the lid to αD of the α/β hydrolase fold
are poorly defined in our electron-density map.
The N-terminal region of AnEH (residues 13–85) forms an
unusual curved meander approximately 60 Å in length. At
the beginning and end of the meander, hydrophobic
sidechains pack onto the α/β hydrolase core. More central
segments interact first with the helices of the lid, then
with the lid of the twofold-related molecule (Figures 1a,2). 
Two cis-prolines are found in each subunit, both at criti-
cal parts of the fold. Pro118 is located at the end of β3 in
a reverse turn adjacent to the active-site nucleophile; the
mainchain carbonyl oxygen of the preceding residue,
Trp117, forms part of the oxyanion hole. Pro158 is part of
the lid support structure at the end of β4. Both regions
are highly conserved in the sequences making up this
subfamily of the epoxide hydrolases, and in many other
α/β hydrolases.
The dimer interaction
Gel filtration chromatography studies suggest that AnEH
is a dimer in solution (M Arand et al., unpublished obser-
vations). In the crystal structure, a dimer is formed about
a nearly perfect noncrystallographic twofold axis (Figure
2) with a total loss of 5500 Å2 of accessible surface area.
The dimer interface results primarily from the interaction
of the lids, and the tips of the N-terminal meanders. The
triangular arrangement of lid helices αLB, αLC and αLD
is centered on the indole ring of Trp276, which in turn
packs against the twofold related shape in the dimer inter-
face. Although most of the sidechains in the interface are
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Figure 2
Stereo ribbon drawing showing the interface
and symmetry of the AnEH dimer interaction.
Both subunits are colored in the rainbow
scheme used in Figure 1. Sidechains of the
dimer interface are shown, as well as a series
of interactions (Trp276, His255, and Tyr314)
that leads from the dimer interface to the
active site.
st8208.qxd  02/29/2000  12:34  Page 114
hydrophobic, there are also many salt links and other polar
interactions. These include the buried but hydrated
Glu254, and a series of interactions leading via the rings of
Trp276, His255 and Tyr314 to the active site (Figure 3).
The tip of each N-terminal meander also interacts with
the lid helices of both monomers so that αLB, αLC and
αLD are almost completely buried within the dimer inter-
face. Consequently, this region has the lowest crystallo-
graphic temperature factors in the entire structure.
The active site
There are two active sites per dimer; each is composed of
residues drawn from a single subunit. The residues
implicated directly in catalysis by analogy to other
enzymes [21] are the catalytic triad of Asp192, His374
and Asp348 (Figure 3). 
The reaction is believed to occur in two steps ([24];
Figure 4). First, a trans-specific attack of Asp192 on the
oxirane ring results in the formation of a covalent
enzyme–substrate ester intermediate. This is thought to
be the rate-determining step for AnEH [21]. It is believed
that a proton-donating group from the protein assists
epoxide ring opening, in a classic push–pull mechanism.
In the second step, the intermediate is hydrolysed by the
attack of a water molecule that has been activated through
proton extraction using the His374–Asp348 charge relay. 
Asp192 is located in the cross-over connection between β5
and αC. The mainchain conformation is strained at this
point, and the residue is one of the two Ramachandran out-
liers in the structure. The local sequence (GGDIGS,
residues 190–195) is rich in glycines, and agrees well with
the generic sm–X–nu–X–sm–sm motif of the α/β fold
hydrolases, where sm is a small residue, nu is the catalytic
nucleophile and X is any residue. The lack of a sidechain at
190 allows the close packing of β5 and αC. Similarly, a
glycine at 194 allows the close proximity of β5 and β3,
whereas a larger sidechain at residue 191 would affect
access to the active site. The other members of the triad are
positioned as expected: His374 lies on the loop between β8
and αF, and Asp348 on the loop between β7 and αE.
Figure 3 shows the hydrogen-bonding network near the
active site. Although there is a hydrogen bond between
His374 and Asp348, the interaction of Oδ1 of Asp192 with
the imadazole ring is more distant, and has poor hydrogen-
bonding geometry. Oδ2 of Asp192, on the other hand,
forms good hydrogen bonds with the mainchain amide
nitrogens of residues 117 and 193. These hydrogen bonds
constitute the classical α/β hydrolase oxyanion hole inter-
actions [9]. The only other nearby contact for Asp192 in
the apo structure is to a water molecule (3.3 Å separation).
This water molecule in turn interacts with the hydroxyl
groups of two tyrosine residues, 251 and 314, whose
sidechains hang down from αLB and αLF of the lid
(Figures 1a,3). These tyrosines are perfectly situated to
act as proton donors for the epoxide ring oxygen, and so to
assist in ring opening in the first step of the reaction. The
Trp276, His255, Tyr314 series of interactions that begins
near the subunit–subunit interface might well affect the
chemical properties of the active-site tyrosine pair in a
manner that is important in catalysis. Such supporting
interactions could, for instance, reduce the pKa of Tyr314
from the normal value of ~10 by delocalising the negative
charge of the deprotonated species.
It was found that mutation of a charge-relay residue in rat
mEH (Glu404→Gln) left some residual activity, and on
this basis it was suggested that Glu376 could contribute
to water activation during the second step of catalysis
[1,17]. Glu376 corresponds to Glu316 in AnEH. This
residue is not, in fact, located in the active site, but is
instead aimed in the opposite direction, forming a hydro-
gen bond with the mainchain nitrogen of Leu166. As
such, it is not in the appropriate location for a catalytic
role, although it might well have an effect on catalysis for
indirect structural reasons. Very recent work has shown
that expression of the Glu376Gln mutant protein in yeast
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Figure 3
Catalytic site residues (Asp192, His374 and Asp348), with the most
important hydrogen-bonding interactions displayed. The water
molecule (red) interacting with Tyr251 and Tyr314 is believed to
indicate the position of the oxirane ring oxygen. Additional water
molecules near the charge-relay residues (His374 and Asp348) and
Glu123 are thought to provide a reservoir of water close to the active
site. The series of interactions leading via the rings of Trp276 and
His255 to the active-site residue Tyr314 is also shown. Colors for the
backbone use the same rainbow scheme found in earlier figures.
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(instead of in bacteria) leads to a fully active mEH
(M Arand et al., unpublished observations).
In contrast, Glu123, which is well conserved in this sub-
family of EHs, could be involved in water activation. This
residue protrudes into the active-site region and is not
involved in hydrogen-bonding interactions with other
protein atoms. The carboxylate group is hydrated, and is
bridged to the imadazole ring of His374 via two water
molecules (Figure 3). The water molecule closest to the
histidine is ideally positioned for the hydrolysis step of
the reaction, and is only 4.2 Å from the carboxylate group
of Glu123.
A previous report that one or more cysteine residues are
important in activity [22] appears to be attributable to the
presence of Cys350 in the wall of the active site.
Full access to the active site is prevented by the α-helical
lid. The known EHs have characteristic enantio- and
regio-selectivities, which can presumably be explained in
terms of the shape and character of the active-site cavity.
AnEH preferentially hydrolyzes the R enantiomer of
mono-substituted oxirane substrates [22], attacking at the
least hindered carbon of the ring. Retention of configura-
tion in the product results, for both R and S enantiomers.
We have modeled the binding of both enantiomers of the
substrate 4-nitrostyrene oxide into the active site, and con-
clude that the selectivity is because of the different direc-
tion of attack by Asp192 on the two substrates. If the
epoxide ring oxygen of the R isomer is placed at the site of
the water interacting with the tyrosines, we can point the
least hindered carbon towards Asp192 while placing the
aromatic ring in the opening to the active site (Figure 5),
in a seemingly optimal arrangement for catalysis. The aro-
matic ring of p-nitrostyrene of this substrate should make
favorable perpendicular stacking interactions to Phe196
and Phe244 [25]. Similarly, the S isomer can be placed in a
position for SN2 attack by Asp192, and for hydrogen
bonding by the two tyrosines. The plane of the epoxide
ring is, however, aligned quite differently with respect to
the catalytic nucleophile, and there will be much more
crowding for substituents to the C7 atom (Figure 5). This
should explain the reduced binding of the S enantiomer of
4-nitrostyrene oxide [26]. Substitution at C8 destroys
activity for both enantiomers, and is probably a result of
close contacts between the substituent and Asp192, as
well as Trp284 and Leu349.
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Figure 4
Mechanism of 4-nitrostyrene oxide hydrolysis by AnEH; residues are
shown as close as possible to their actual relative orientation and
position. Initial binding and positioning of the substrate in the active
center of the enzyme is thought to be directed by hydrogen bonding
between the epoxide ring oxygen and the hydroxyl groups of Tyr251
and Tyr314. In the first step of the enzymatic reaction, the carboxylate
sidechain of the catalytic nucleophile Asp192 attacks the
unsubstituted carbon atom of the oxirane ring, forming an ester bond
and opening the ring. The process is facilitated through simultaneous
proton donation by one of the tyrosine residues (the series of
hydrogen bonds between the pi system of Tyr314 and His255/Trp276
discussed in the main text favors Tyr314, as it is expected to result in
a lower pKa). The two parts together comprise a classic push–pull
mechanism. The second step of the reaction consists of the
hydrolysis of the ester intermediate via the attack of a water molecule.
This water is activated through proton abstraction by the
His374/Asp348 charge-relay system, possibly further assisted by
Glu123 (not shown).
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Similarity to other epoxide hydrolases
Sequence similarity between mEH and sEH could not be
detected directly, but was discovered through their
common similarity to sequences of the α/β hydrolase fold
family [6]. The structure of the EH from Agrobacterium
radiobacter was reported recently [20], the first EH struc-
ture to be published. This enzyme represents the sub-
family of sEH proteins, as AnEH exemplifies the mEH
branch. Table 3 gives some comparative information for
the two EH structures; they are superimposed in Figure 6.
There is 19% sequence identity in equivalent segments of
the bacterial protein and AnEH. Two residues of the cat-
alytic triad, those equivalent to Asp192 and His374, are
placed in an equivalent manner in a similar structural
setting. Surprisingly, the authors state that the third
member of the triad (Asp246) is forced out of the active
site by non-productive binding of Gln134, which they
attribute to crystal-packing effects.
The two hydrogen-bond donors of AnEH that are
believed to assist in ring opening, Tyr251 and Tyr314,
are conserved as Tyr152 and Tyr215 in the bacterial
enzyme. Tyr→Phe mutations of both these donors
together dramatically impair performance of the enzyme
(referred to as unpublished work in [20]), supporting
their role as important players in catalysis. The hydro-
gen-bonding interactions observed to support Tyr314 in
AnEH (Figure 3) are also conserved in the bacterial
protein as His156 (equivalent to His255) and Tyr175
(equivalent to Trp276). Other differences in the active-
site region of the enzymes are presumably responsible
for their respective substrate specificities (for example,
Leu193 of AnEH is changed to Phe108 in the
bacterial protein).
Although the authors state that the bacterial enzyme is
monomeric [20], there are four molecules of the bacterial
EH in the reported asymmetric unit. These, in fact, repre-
sent two pairs of dimers that are very similar to the dimer
observed for AnEH. We calculate the total buried surface
area for each dimer in the bacterial EH crystal to be
1200 Å2. This suggests that a dimer is present in solution,
perhaps in a reversible equilibrium with the monomer. As
with AnEH, the dimer interface is mostly hydrophobic in
character (for example, the Trp151/ Phe155/Leu158/
Val164/Tyr175 cluster), although the residues involved
are not well conserved between the two proteins. The
smaller size of the contact surface in the bacterial enzyme
is largely because of its lack of the N-terminal meander.
Some other epoxide hydrolases have been reported to
exist as dimers in solution, including the human sEH [27]
as well as the soybean enzyme [28].
The structure of the murine sEH has been published very
recently [29]. As coordinates are not yet available, and the
resolution of the sEH structure is also lower than for
AnEH, our comparisons must at present remain qualitative.
The catalytic acid of sEH is Asp333, and is supported by
nearby charge-relay residues (His523 and Asp495). Tyro-
sine residues 381 and 465 appear to take on the positions of
251 and 314 of AnEH, although the authors considered
only the significance of Tyr381 in catalysis. All of the avail-
able evidence points to a catalytic mechanism similar to
that used by AnEH.
The approximately 30% sequence identity of AnEH to
the human mEH allowed us to build a model of the latter
enzyme, based on our coordinates. The residues of the
catalytic triad [18] can be placed with great confidence.
The nucleophile, Asp226, and His431 of the charge relay
replace the equivalent residues of AnEH. The substitu-
tion of Asp348 with Glu404 in the mEH charge-relay
system might slow down the hydrolysis step and thus con-
tribute to the fact that this step is rate-limiting for the
mammalian enzyme [1,21]. Indeed, a replacement of
Glu404 with an aspartic acid leads to a strongly increased
turnover rate, with altered kinetic characteristics that
support such an interpretation [18]. Although sequence
relationships are weaker in the lid, Tyr299 and Tyr374
appear in equivalent positions to the two tyrosines of the
AnEH active site. The residues that support these two
tyrosines in AnEH are mutated in mEH: His255 is
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Figure 5
Substrate 4-nitrostyrene oxide docked into the active site of the apo
enzyme, shown with a solvent accessible surface. The site is
complementary to the R enantiomer (green carbon atoms), and a
poorer fit for the S enantiomer (yellow carbon atoms). The close
contact (< 3 Å) expected between C7 of the S isomer and the hydroxyl
group of Tyr251 is shown.
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replaced by Gln303, and Trp226 by Tyr324. Although
details of the mEH structure are impossible to predict,
mutations such as Phe196→Leu230, Cys350→Phe406,
and Phe244→Ser292 appear likely to alter the shape and
character of the active-site cavity and help rationalize why
mEH is able to hydrolyse a broad range of monosubsti-
tuted and cis-disubstituted epoxides, whereas AnEH can
hydrolyze only monosubstituted epoxides efficiently.
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Figure 6
Superposition of the agrobacterial EH (black)
on AnEH (rainbow coloring), showing
similarity of the active-site region and lid. The
known residues of catalysis are included;
dashed lines indicate the location of the
disordered regions of the two proteins.
Table 3
Comparison to other known structures.
Protein (Source) No. No. atoms within a  Rms difference PDB code and  Nucleophile Charge-relay
residues 3.8 Å cut-off to AnEH (Å) reference residues
(% identical of matched)
Equiv. to Equiv. to Equiv. to
Asp192 His374 Asp348
Bacterial EH 282 224 (18.8) 1.72 1EHY [20] Asp107 His275 Asp246?
(Agrobacterium radiobacter)
Bromoperoxidase A2 277 193 (13.5) 1.95 1BRO [61] Ser98 His257 Asp228
(Streptomyces aureofaciens)
Chloroperoxidase F 273 194 (16.5) 1.97 1A8S [62] Ser94 His253 Asp224
(Pseudomonas fluorescens)
Chloroperoxidase L 275 192 (16.9) 1.99 1A88 [62] Ser96 His255 Asp226
(Streptomyces lividans)
Bromoperoxidase A1 274 182 (12.7) 1.88 1A8Q [62] Ser94 His252 Asp223
(Streptomyces aureofaciens)
Haloalkane dehalogenase 310 167 (16.2) 2.13 2HAD [9] Asp124 His289 Asp260
(Xanthobacter autotrophicus)
Hydroxynitrile lyase 256 149 (10.7) 1.85 1YAS [63] Ser80 His235 Asp207
(Hevea brasiliensis)
Proline iminopeptidase 313 155 (17.4) 1.95 1AZW [64] Ser110 His294 Asp266
(Xanthomona campestis)
Lipase 317 103 (12.6) 2.11 1TCB [65] Ser105 His224 Asp187
(Candida antarctica)
The putative third member of the charge relay of the bacterial EH is indicated with a question mark, although the currently available structure does
not place this residue in the appropriate position. Equiv., equivalent.
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The N-terminal meander of AnEH is preserved intact in
mEH, and augmented with a membrane anchor. The
extension is characteristic of the subfamily, and its impor-
tance in dimer formation in AnEH suggests that mEH will
also be dimeric. The low level of the sequence identity,
however, makes absolute statements impossible. Because
mEH is membrane-bound, this aspect of its structure has
so far remained unexplored. The presence of two mem-
brane anchors in an mEH dimer could, however, have
important consequences for function, for example, by pre-
orienting the enzyme for binding of either substrates or
functional partners.
Relationship to other α/β hydrolase structures
Sequence relationships of EHs to other enzymes in the
α/β hydrolase family had suggested a structural relation-
ship [6,30] that is confirmed by the AnEH structure.
Table 3 shows a comparison of the structure of AnEH to
the most similar models currently available in the
Protein Data Bank [31].
Greatest similarity among the group members is main-
tained in the region of the α/β hydrolase fold (Figure 7).
This portion bears the nucleophile, either serine or
aspartic acid, as required by the chemistry of the reac-
tion. In the EHs, for example, attack by a serine nucle-
ophile (like that found in bromoperoxidases) would
result in an overly stable reaction intermediate, and
therefore aspartate is used instead. Each of the proteins
listed here utilizes a histidine/aspartate charge relay,
although the aspartate might be replaced by a
glutamate in other family members. The bacterial EH
appears to be the only case of an EH/HAD family
member for which the catalytic triad is reported to be
incomplete [20].
Increasing differences in lid design explain most of the
progressive decrease in the number of equivalent residues
as the structures diverge. Although each enzyme retains
some sort of lid structure, the basic requirements can
clearly be met in a number of ways that can be tailored to
suit the individual reactions. Only the bacterial EH retains
helices in positions equivalent to all six of the lid helices of
AnEH. With the exception of the Candida antarctica lipase
(which lacks a lid), the others possess helices equivalent to
αLD, αLE, and (except the hydroxynitrile lyase) αLF.
Lid groups that correspond to the active-site tyrosines of
AnEH are frequent features, including for example,
Trp127 and Trp175 in the haloalkane dehalogenase. 
Biological implications
The structure of Aspergillus niger epoxide hydrolase
(AnEH) is representative of the family of microsomal
epoxide hydrolases (mEHs) and thus gives insights into
several previously unresolved issues. The shape of the
substrate-binding site, with the catalytic nucleophile
waiting for the substrate at the end of a relatively
narrow hydrophobic tunnel, offers a perfect explanation
for the observed inability of this class of EHs to
hydrolyze the bulky trans-substituted epoxides. In addi-
tion, two tyrosine residues are observed in the active site
that can bind the ring oxygen of the epoxide and assist
catalysis by subsequent proton donation. They can also
serve to bind fatty acid amides, which are known
inhibitors of mammalian mEHs [32], via an interaction
of their carbonyl moiety. 
Possible physical interactions of mEHs with other
enzymes of the xenobiotic metabolism cascade have long
been postulated [33,34]. The N-terminal portion of the
protein that precedes the canonical core α/β hydrolase
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Figure 7
Structural alignments of the proteins listed in
Table 3, showing the similarity of the α/β
domains and the different construction of the
lids. AnEH is shown in black, the bacterial EH
in red, bromoperoxidase A2 in magenta,
chloroperoxidase F in gold, chloroperoxidase
L in green, bromoperoxidase A1 in cyan,
haloalkane dehalogenase in yellow,
hydroxynitrile lyase in blue, proline
iminopeptidase in maroon, and the lipase in
lime green.
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fold of the family of epoxide hydrolases and haloalkane
dehalogenases is unique to the mEHs, and could thus be
suspected of mediating such an interaction. Based on the
three-dimensional structure, however, it can no longer be
favored in this role because of its distance from the sub-
strate entry site. On the other hand, a poorly ordered
loop immediately adjacent to this entry (residues 320–328
in the current model), offers a tempting possibility for
reversible contacts with, for example, epoxide-generating
cytochrome P450-dependent monooxygenases. Sugges-
tions that mEH might be a dimer offer additional intrigu-
ing possibilities for the design of biochemical
experiments. 
Recently, mammalian mEH has been reported to be a
membrane transporter for bile acids, although this issue
is presently a matter of debate [35–37]. Based on the
structure of AnEH, we suggest that mammalian mEH is
unlikely to act as a membrane transporter. There is no
indication of a structural element other than the mEH
N-terminal membrane anchor (not present in AnEH)
that could span a lipid membrane. 
Finally, the three-dimensional structure of AnEH pro-
vides a basis for the rational design of mutants of the
enzyme with altered substrate preference and enhanced
enantioselectivity, further increasing its value as a bio-
catalyst in the production of fine chemicals.
Materials and methods
Purification and crystallization
AnEH from Aspergillus niger strain LCP521 (EMBL accession number
AJ238460) was over-expressed and purified in a manner similar to that
described previously [21]. The expression construct was modified to
enhance translation efficiency in Escherichia coli by improving the
binding to the 16S ribosomal RNA [38]. A stretch of 15 nucleotides
was inserted into the 5′-end of the AnEH coding region resulting in the
sequence ATG TCC GCT Ctc atg aat cac aaa gCG TTC (start codon
italicized; insert shown in lower case letters). This altered the N-terminal
sequence of the protein from MSAPF to MSALMNHKAF. Native
enzyme was expressed in the E. coli strain BL21(DE3): a 3 l culture in
terrific broth [39] was supplemented with 100 mg ampicillin per litre,
and grown at 12% oxygen saturation, in a fermentor (30°C). T7 RNA
polymerase was induced with 0.4 mM IPTG (isopropyl-β-D-thiogalac-
tose) at OD600 = 15, and the cells harvested 2.5–3 h later. Purification
of the native protein was as previously described. 
For the MAD experiments, the enzyme was expressed in the met–
E. coli strain B834(DE3), using M9 minimal medium supplemented
with amino acids (5 mg/l each of tryptophan and tyrosine, 40 mg/l of
selenomethionine, and 50 mg/l each of the other 17 amino acids), 4 g/l
glucose and 100 mg/l ampicillin. Because of the reduced growth of the
bacteria under these conditions, IPTG was added at an OD600 of 1.0.
Purification of Se-AnEH was as described above, except that 1 mM
DTT was included in all buffers. Because of its lower solubility, the
SeMet–protein had to be eluted from the Phenyl Sepharose column
(the second chromatographic step in the purification) with 50% glyc-
erol in 5 mM Tris-HCl pH 8, 0.5 mM EDTA, 1 mM DTT. The incorpora-
tion of SeMet was confirmed by a total amino acid analysis (using
β-mercaptosulfonic acid hydrolysis to avoid methionine degradation).
Crystallization trials were carried out using the sitting-drop vapour diffu-
sion method [40] in microbridges [41] at 277K. Two commercial kits
(Hampton I, Wizard I), based on the sparse matrix designs of Jancarik
and Kim [42]; Hampton Research, California) and Safarty and Hol
(described in [43]; Emerald BioStructures, Bainbridge Island, Wash-
ington), respectively, were used for screening. Crystals grew readily
under a variety of conditions. The best-diffracting crystals were
obtained by mixing 2 µl of the protein solution (17 mg/ml in a buffer of
10 mM Tris-HCl pH 7.4, 1 mM EDTA, 20 mM NaCl and 0.02% sodium
azide) with 2 µl of the reservoir (20% PEG 6000, 0.1 M MES pH 6.0
and 0.1 M unbuffered sodium acetate). Crystals (0.3 × 0.4 × 0.02 mm)
grew within one week. The Se-AnEH was concentrated to 30 mg/ml in
l0 mM Tris pH 7.4, 1 mM EDTA, 20 mM NaCl, 1 mM DTT, excluding
azide, for crystallization trials. Successful conditions were similar to
those for the native protein, except that the reservoir contained 10%
rather than 20% PEG 6000. β-Mercaptoethanol (0.1%) was initially
included in the reservoirs to prevent oxidation of the selenium, in addi-
tion to the DTT present in the buffer. This was found to be unnecessary
and therefore omitted in later experiments. The drops were streak-
seeded [44] with native crystals; a single grain of sand was also added
to some drops [45]. Addition of the sand nucleant resulted in thicker
crystals with identical morphology. 
Data collection, structure solution and refinement
Native crystals were flash-frozen in liquid nitrogen after a 1 min soak in
a cryoprotectant solution (30% PEG 6000, 0.1 M MES pH 6.0, 0.1 M
sodium acetate). They diffracted to 2.5 Å on a home X-ray source, and
to 1.8 Å at the ESRF (Grenoble) ID14 EH4 beam line. The Se-substi-
tuted crystals were cryoprotected in the same manner, and a three-
wavelength MAD dataset collected on the same ESRF beamline. An
X-ray absorption spectrum was collected near the Se K-absorption
edge for Se-AnEH by measuring the fluorescent signal perpendicular
to the beam during an energy scan. Data were then collected to 2.7 Å
resolution at wavelengths corresponding to the inflection point of the
spectra (12657 eV), the peak of the spectra (12659 eV), and a remote
wavelength at the peak brilliance of the beamline at 13315 eV. The
data were acquired on an ADSC Quantum-4 charged coupled device
(CCD) detector using 1° oscillations. No measures were taken to
record the Bijvoet pairs close in time or to reduce absorption effects by
crystal alignment or reverse-beam procedures. The MAD data collec-
tion, including change of wavelengths, was completed in 2 h. All
images were integrated and scaled using the HKL suite of programs
[46]. Statistics relating to crystal quality and data collection are sum-
marized in Table 1.
The sites of 15 of the possible 22 selenium atoms were located, refined
and used for phasing in the program package SOLVE [47]. Inspection
of a solvent-flattened map generated by DM [48,49] phased to 3.5 Å
resolution clearly showed a closely entwined dimer with good solvent
separation. An approximate NCS operator was determined by building a
number of short equivalent α-helical fragments in O [50]. This operator
was improved using IMP [51] and the map cyclically averaged using
DM. The first model was built in O using skeletons, mainchain and
sidechain databases [52]; numbering was according to the sequence of
the wild-type protein, with an asparagine as residue 1 instead of the
wild-type methionine (see above). Refinement was carried out with the
high-resolution native dataset. CNS [53] was used throughout the
refinement with force field parameters derived from the small-molecule
database [54]. NCS restraints were relaxed as the refinement pro-
gressed. After the second refinement-rebuilding macro-cycle, waters
were added using wARP [55]. Only water molecules satisfying the NCS
were included in subsequent rounds of refinement. Statistics for the final
model are shown in Table 2. 
Surface accessibility calculations were carried out using the algorithm
of Lee and Richards [56]. Coordinates of similar proteins were
obtained from the PDB [31]. Similar proteins were identified using the
bromoperoxidase A2 structure as an intermediate step, that is, defined
as proteins with Z scores greater than 5.5 to 1BRO in the RCSB PDB
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(http://www.rcsb.org/pdb/) according to Combinatorial Extension [57].
These structures were then compared with AnEH using the brute and
imp options of the program LSQMAN [58,59]. Where more than one
molecule is present in the asymmetric unit, the A chain was used for
the analysis. Figures were prepared with the programs O and OPLOT
[50], POV-Ray version 3.1 (http://www.povray.org), and Canvas 6
(Deneba Systems, Inc.).
Accession numbers
Coordinates and structure factors have been deposited at the Protein
Data Bank with tracking code 1QO7.
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